JPS49102660A - - Google Patents

Info

Publication number
JPS49102660A
JPS49102660A JP49016151A JP1615174A JPS49102660A JP S49102660 A JPS49102660 A JP S49102660A JP 49016151 A JP49016151 A JP 49016151A JP 1615174 A JP1615174 A JP 1615174A JP S49102660 A JPS49102660 A JP S49102660A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49016151A
Other languages
Japanese (ja)
Other versions
JPS6117840B2 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS49102660A publication Critical patent/JPS49102660A/ja
Publication of JPS6117840B2 publication Critical patent/JPS6117840B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP49016151A 1973-02-08 1974-02-08 Expired JPS6117840B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7304567A FR2217324B1 (cg-RX-API-DMAC7.html) 1973-02-08 1973-02-08

Publications (2)

Publication Number Publication Date
JPS49102660A true JPS49102660A (cg-RX-API-DMAC7.html) 1974-09-27
JPS6117840B2 JPS6117840B2 (cg-RX-API-DMAC7.html) 1986-05-09

Family

ID=9114573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49016151A Expired JPS6117840B2 (cg-RX-API-DMAC7.html) 1973-02-08 1974-02-08

Country Status (6)

Country Link
JP (1) JPS6117840B2 (cg-RX-API-DMAC7.html)
BE (1) BE810787A (cg-RX-API-DMAC7.html)
CH (1) CH603692A5 (cg-RX-API-DMAC7.html)
DE (1) DE2405876C3 (cg-RX-API-DMAC7.html)
FR (1) FR2217324B1 (cg-RX-API-DMAC7.html)
GB (1) GB1461444A (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
CH603692A5 (cg-RX-API-DMAC7.html) 1978-08-31
JPS6117840B2 (cg-RX-API-DMAC7.html) 1986-05-09
DE2405876A1 (de) 1974-08-22
BE810787A (fr) 1974-08-08
FR2217324A1 (cg-RX-API-DMAC7.html) 1974-09-06
DE2405876B2 (de) 1978-07-06
DE2405876C3 (de) 1979-03-01
FR2217324B1 (cg-RX-API-DMAC7.html) 1977-02-04
GB1461444A (en) 1977-01-13

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC7.html)
AU476761B2 (cg-RX-API-DMAC7.html)
AU465372B2 (cg-RX-API-DMAC7.html)
AR201235Q (cg-RX-API-DMAC7.html)
AR201231Q (cg-RX-API-DMAC7.html)
AU474593B2 (cg-RX-API-DMAC7.html)
AU474511B2 (cg-RX-API-DMAC7.html)
AU474838B2 (cg-RX-API-DMAC7.html)
AU471343B2 (cg-RX-API-DMAC7.html)
AU465453B2 (cg-RX-API-DMAC7.html)
AU465434B2 (cg-RX-API-DMAC7.html)
AU450229B2 (cg-RX-API-DMAC7.html)
AU476714B2 (cg-RX-API-DMAC7.html)
AR201229Q (cg-RX-API-DMAC7.html)
AU466283B2 (cg-RX-API-DMAC7.html)
AU472848B2 (cg-RX-API-DMAC7.html)
AU476696B2 (cg-RX-API-DMAC7.html)
AR199451A1 (cg-RX-API-DMAC7.html)
AU477823B2 (cg-RX-API-DMAC7.html)
AR197627A1 (cg-RX-API-DMAC7.html)
AR193950A1 (cg-RX-API-DMAC7.html)
AR200885A1 (cg-RX-API-DMAC7.html)
AR210729A1 (cg-RX-API-DMAC7.html)
AU477824B2 (cg-RX-API-DMAC7.html)
AU447540B2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 19831025

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19861021